| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |